会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • NOVEL SUBSTITUTED AZABENZOXAZOLES
    • 新型取代的AZABENZOXAZOLES
    • US20110085985A1
    • 2011-04-14
    • US12995314
    • 2009-05-28
    • James C. BarrowScott HarrisonJames MulhearnCyrille SurDavid L. WilliamsScott Wolkenberg
    • James C. BarrowScott HarrisonJames MulhearnCyrille SurDavid L. WilliamsScott Wolkenberg
    • A61K31/437C07D498/04C07D519/00A61K31/5377A61K49/00A61K49/04A61K49/06A61P25/28A61P25/18
    • C07D498/04C07D519/00
    • The present invention relates to novel amyloid binding compounds of formula (I) and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET/) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted azabenzoxazole derivatives, compositions, and therapeutic uses and processes for making such compounds, or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof, wherein: X is O or S; A and Y independently are N, or CH;
    • 本发明涉及式(I)的新型淀粉样蛋白结合化合物和通过测定活体患者淀粉样斑块水平的变化来测定化合物的效果的方法。 更具体地说,本发明涉及使用本发明化合物作为正电子发射断层摄影(PET /)成像中的示踪剂来研究脑中淀粉样蛋白沉积物以允许诊断阿尔茨海默病的方法。 因此,本发明涉及新型淀粉样蛋白结合化合物作为诊断用途。 本发明还涉及测量阿尔茨海默病治疗剂的临床疗效的方法。 具体地,本发明涉及新的芳基或杂芳基取代的氮杂苯并恶唑衍生物,组合物,以及用于制备这些化合物或其药学上可接受的盐,溶剂合物或体内可水解的酯的治疗用途和方法,其中:X是O或S; A和Y独立地为N或CH;
    • 4. 发明申请
    • NOVEL SUBSTITUTED AZABENZOXAZOLES
    • 新型取代的AZABENZOXAZOLES
    • US20110212031A1
    • 2011-09-01
    • US13125939
    • 2009-10-21
    • Cyrille SurDavid L. Williams
    • Cyrille SurDavid L. Williams
    • A61K49/10A61P25/16A61K31/5377A61K49/00A61P25/28A61P25/18A61K31/437
    • A61K31/519A61K51/0455A61K51/0463
    • The present invention relates to novel MAO-B binding compounds and methods for measuring effects of the compounds, by measuring changes of MAO-B levels in living patients. More specifically, the present invention relates to use of the compounds of this invention as therapeutic agents for inhibition of MAO-B activity as well as a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study MAO-B levels in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel MAO-B binding compounds as diagnostic, as we a therapeutic, agents. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted azabenzoxazole derivatives, compositions, and therapeutic uses and processes for making such compounds.
    • 本发明涉及通过测量活体患者中MAO-B水平的变化来测量化合物的效果的新型MAO-B结合化合物和方法。 更具体地,本发明涉及本发明化合物作为抑制MAO-B活性的治疗剂的用途以及使用本发明化合物作为正电子发射断层摄影(PET)成像中的示踪物来研究MAO的方法 -B水平在体内,以允许诊断阿尔茨海默病。 因此,本发明涉及新型MAO-B结合化合物作为诊断的用途,作为治疗剂。 本发明还涉及测量阿尔茨海默病治疗剂的临床疗效的方法。 具体地,本发明涉及新的芳基或杂芳基取代的氮杂苯并恶唑衍生物,组合物,以及用于制备这些化合物的治疗用途和方法。
    • 5. 发明授权
    • Mobile client device driven data backup
    • 移动客户端设备驱动的数据备份
    • US09128882B2
    • 2015-09-08
    • US11835628
    • 2007-08-08
    • David L. Williams
    • David L. Williams
    • G06F17/30G06F11/14H04W8/22
    • G06F11/1448G06F11/1464G06F11/1469H04W8/22
    • Tasks associated with backing up the data of a mobile client device are performed predominantly by the mobile client device. A backup server functions as a server with limited functionality that merely stores backup data received from the mobile client device and retrieves the backup data under the request of the mobile client device. The mobile client device functions as a master device, and the backup server functions as a slave device. A backup program for performing tasks associated with the backup operation on the mobile client device may itself be stored as part of the backup data.
    • 与备份移动客户端设备的数据相关联的任务主要由移动客户端设备执行。 备份服务器用作具有有限功能的服务器,其仅存储从移动客户端设备接收的备份数据,并在移动客户端设备的请求下检索备份数据。 移动客户端设备作为主设备,备份服务器用作从设备。 用于执行与移动客户端设备上的备份操作相关联的任务的备份程序本身可以被存储为备份数据的一部分。
    • 6. 发明申请
    • IR SENSOR USING REO UP-CONVERSION
    • IR传感器使用REO UP转换
    • US20120241890A1
    • 2012-09-27
    • US13053285
    • 2011-03-22
    • Andrew ClarkErdem ArkunRytis DargisDavid L. Williams
    • Andrew ClarkErdem ArkunRytis DargisDavid L. Williams
    • H01L31/0232H01L31/18
    • H01L31/02322G01J1/58G01J5/20H01L31/02327H01L31/103Y02E10/52
    • A pumped sensor system includes a substrate with a first layer formed thereon and doped for a first type conduction and a second layer doped for a second type conduction, whereby the first and second layers form a silicon light detector at an up-conversion wavelength. A ternary rare earth oxide is formed on the second layer and crystal lattice matched to the second layer. The oxide is a crystalline bulk oxide with a controlled percentage of an up-conversion component and a majority component. The majority component is insensitive to any of pump, sense, or up-conversion wavelengths and the up-conversion component is selected to produce energy at the up-conversion wavelength in response to receiving energy at the pump and sense wavelengths. The layer of oxide defines a light input area sensitive to a pump wavelength and a light input area sensitive to a sense wavelength.
    • 泵送传感器系统包括其上形成有第一层并且被掺杂用于第一类型传导的第一层和掺杂用于第二类型传导的第二层的衬底,由此第一和第二层以上转换波长形成硅光检测器。 在第二层上形成三元稀土氧化物,并且与第二层匹配的晶格。 氧化物是具有受控百分比的上转换组分和多数组分的结晶体氧化物。 大多数组件对泵,感测或上转换波长中的任何一个不敏感,并且上转换组件被选择为响应于在泵处的接收能量和感测波长而在上转换波长处产生能量。 氧化物层限定对泵浦波长敏感的光输入区域和对感测波长敏感的光输入区域。